NICE decision-making needs scrutiny19th December 2008
The Royal College of Nursing has said that there needs to be a proper debate on changes to the NHS's approach to resource allocation.
The RCN said that it agrees that the National Institute for Health and Clinical Excellence (NICE) should place more value on medicines that extend life or treat terminal conditions. The views have been set out in the college’s response to NICE's consultation on appraising end-of-life medicines where it says that more debate is required on factors important to patients in making resource allocation decisions.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.